Medications associated with weight gain
Pro Research Analysisby 
Searched over 200M research papers
Medications Associated with Weight Gain: Key Drug Classes and Agents
Weight gain is a well-documented side effect of several commonly prescribed medications, with significant variation both between and within drug classes. The degree of weight gain can differ based on individual patient factors and the specific medication used 110.
Psychotropic Medications and Weight Gain
Antipsychotics
Most antipsychotic medications are linked to weight gain, with the highest risk seen in drugs like olanzapine and clozapine. Other antipsychotics such as quetiapine, risperidone, and haloperidol also contribute to significant weight increases, especially in the early stages of treatment. Children and adolescents are particularly vulnerable to this effect 3478+1 MORE. The weight gain is often rapid initially and may plateau over time .
Antidepressants
Many antidepressants are associated with weight gain, but the risk varies widely. Mirtazapine and amitriptyline are among those most likely to cause weight gain, while bupropion is associated with weight loss. The mechanisms often involve effects on appetite-regulating pathways, such as histamine and serotonin receptors 67410. Selective serotonin reuptake inhibitors (SSRIs) and other antidepressants can also lead to weight gain, though the extent depends on the specific agent 67.
Mood Stabilizers and Other Psychotropics
Lithium and valproic acid, commonly used mood stabilizers, are also linked to weight gain, though the extent may be less than previously thought 59. Some anticonvulsants, such as gabapentin, can also cause weight gain, while others like topiramate and zonisamide are associated with weight loss .
Other Medication Classes Associated with Weight Gain
Diabetes Medications
Several drugs used to treat diabetes, including insulin, sulfonylureas (e.g., glimepiride, glyburide, glipizide), and thiazolidinediones (e.g., pioglitazone), are associated with weight gain. In contrast, metformin, acarbose, and GLP-1 receptor agonists (e.g., liraglutide, exenatide) are linked to weight loss 102.
Cardiovascular Medications
Beta-blockers, commonly prescribed for hypertension and heart disease, have been shown to contribute to weight gain, particularly in postmenopausal women .
Clinical Impact and Management Strategies
Weight gain from medications can lead to increased risk of obesity, cardiovascular disease, and reduced quality of life. It is also a major reason for poor adherence or discontinuation of treatment, especially in psychiatric populations 359. The best approach is to prevent weight gain when possible by selecting alternative medications with lower risk, providing dietary counseling, and monitoring weight regularly 1459.
Lifestyle interventions, including diet and exercise, are effective for managing medication-induced weight gain. Pharmacological options such as metformin and GLP-1 receptor agonists have shown promise, particularly for antipsychotic-induced weight gain, but should be considered carefully due to potential side effects 349.
Conclusion
Several commonly prescribed medications—including many antipsychotics, antidepressants, mood stabilizers, diabetes drugs, and beta-blockers—are associated with clinically significant weight gain. The risk varies by drug and individual patient factors. Prevention and early intervention, including careful medication selection and lifestyle modification, are key to minimizing this side effect and improving treatment adherence and overall health outcomes 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic